Andrew McCrodan is a Tax Services partner in the Tax practice in the downtown Toronto office of PricewaterhouseCoopers LLP. He is part of the Transfer Pricing practice.
Andrew’s extensive cross border experience includes prospective studies for planning purposes, income tax audit defences, contemporaneous documentation engagements, competent authority assistance and advance pricing agreements (APAs). He has helped clients obtain unilateral and bilateral APAs in a variety of industries including consumer products, manufacturing, automotive, retail and software.
When Andrew began his career in transfer pricing at PricewaterhouseCoopers’ New York office in 1994, he helped companies comply with the first contemporaneous documentation requirements. He has been a partner since 1997.
Andrew is a CA and a Chartered Business Valuator (CBV). He placed 20th and 1st in Canada respectively. As a CBV, Andrew brings a wealth of valuation experience to international restructuring, cost sharing and intellectual property migration assignments.
Andrew speaks regularly on transfer pricing and business valuation topics for a number of professional organizations. He has also written articles for CA Magazine, the Canadian Tax Foundation, the Journal of Business Valuation and Tax Planning International Review on the topic of transfer pricing. He co-authored the articles “The Dilemma of GlaxoSmithKline: Unreasonable in the Circumstances?” and “Transfer Pricing: A Critique of the CCRA’s Position on Range Issues.”
Andrew has appeared in the Guide to the World’s Leading Transfer Pricing Advisers since 2003.